Edition:
United States

Johnson & Johnson (JNJ)

JNJ on New York Consolidated

125.66USD
28 Mar 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$125.66
Open
--
Day's High
--
Day's Low
--
Volume
4
Avg. Vol
7,168,270
52-wk High
$129.00
52-wk Low
$107.69

JNJ

Chart for JNJ

About

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer... (more)

Overall

Beta: 0.80
Market Cap(Mil.): $340,650.69
Shares Outstanding(Mil.): 2,710.89
Dividend: 0.80
Yield (%): 2.55

Financials

  JNJ Industry Sector
P/E (TTM): 21.17 29.24 29.98
EPS (TTM): 5.94 -- --
ROI: 15.00 13.55 13.08
ROE: 23.37 14.45 14.23

J&J, JPMorgan suspend YouTube ads over offensive videos

U.S. healthcare conglomerate Johnson & Johnson and JPMorgan Chase & Co became the latest big U.S. companies to suspend all digital advertising on Google's YouTube, over concerns that its ads may have appeared on channels that broadcast offensive videos. | Video

Mar 23 2017

UPDATE 3-J&J, JPMorgan suspend YouTube ads over offensive videos

March 23 U.S. healthcare conglomerate Johnson & Johnson and JPMorgan Chase & Co became the latest big U.S. companies to suspend all digital advertising on Google's YouTube, over concerns that its ads may have appeared on channels that broadcast offensive videos.

Mar 23 2017

J&J latest to suspend ads from YouTube over offensive videos

March 23 U.S. healthcare conglomerate Johnson & Johnson became the latest company to suspend all digital advertising on Google's YouTube, over concerns that its ads may have appeared on channels that broadcast offensive videos.

Mar 23 2017

BRIEF-Johnson & Johnson says to pause all YouTube digital advertising globally

* Johnson & Johnson - decided to pause all YouTube digital advertising globally

Mar 23 2017

BRIEF-J&J CEO Alex Gorsky's 2016 total compensation $26.9 mln

* J&J - CEO Alex Gorsky's 2016 total compensation was $26.9 million versus $23.8 million in 2015

Mar 15 2017

Appeals court revives vaginal sling cases against J&J unit

A federal appeals court on Thursday revived claims by 12 Minnesota women against Johnson & Johnson’s Mentor Worldwide unit, the former maker of the ObTape transvaginal sling, reversing a lower-court ruling that their lawsuits were filed too late.

Mar 09 2017

BRIEF-Janssen provides Nuevolution with further technology access fee payment

* Nuevolution announces further technology access fee payment from its drug discovery collaboration with Janssen Biotech, Inc. (Janssen)

Mar 06 2017

Johnson & Johnson wins trial in talc product liability lawsuits

Johnson & Johnson said on Friday that a state court jury in Missouri had returned a verdict in its favor in the latest trial to arise out of thousands of lawsuits alleging the company's talc-based products can increase the risk of ovarian cancer.

Mar 03 2017

J&J wins trial in talc product liability lawsuits

Johnson & Johnson said on Friday that a state court jury in Missouri had returned a verdict in its favor in the latest trial to arise out of thousands of lawsuits alleging the company's talc-based products can increase the risk of ovarian cancer.

Mar 03 2017

UPDATE 1-J&J wins trial in talc product liability lawsuits

March 3 Johnson & Johnson said on Friday that a state court jury in Missouri had returned a verdict in its favor in the latest trial to arise out of thousands of lawsuits alleging the company's talc-based products can increase the risk of ovarian cancer.

Mar 03 2017

More From Around the Web

Earnings vs. Estimates